Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24,749 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
TP53/mTORC1-mediated bidirectional regulation of PD-L1 modulates immune evasion in hepatocellular carcinoma.
Yu J, Ling S, Hong J, Zhang L, Zhou W, Yin L, Xu S, Que Q, Wu Y, Zhan Q, Bao J, Xu N, Liu Y, Chen K, Wei X, Liu Z, Feng T, Zhou L, Xie H, Wang S, Liu J, Zheng S, Xu X. Yu J, et al. Among authors: xu n, xu s, xu x. J Immunother Cancer. 2023 Nov 29;11(11):e007479. doi: 10.1136/jitc-2023-007479. J Immunother Cancer. 2023. PMID: 38030304 Free PMC article.
Enhancing the Efficacy and Safety of Doxorubicin against Hepatocellular Carcinoma through a Modular Assembly Approach: The Combination of Polymeric Prodrug Design, Nanoparticle Encapsulation, and Cancer Cell-Specific Drug Targeting.
Xu L, Xu S, Wang H, Zhang J, Chen Z, Pan L, Wang J, Wei X, Xie H, Zhou L, Zheng S, Xu X. Xu L, et al. Among authors: xu s, xu x. ACS Appl Mater Interfaces. 2018 Jan 31;10(4):3229-3240. doi: 10.1021/acsami.7b14496. Epub 2018 Jan 22. ACS Appl Mater Interfaces. 2018. PMID: 29313660
USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1α/USP22 positive feedback loop upon TP53 inactivation.
Ling S, Shan Q, Zhan Q, Ye Q, Liu P, Xu S, He X, Ma J, Xiang J, Jiang G, Wen X, Feng Z, Wu Y, Feng T, Xu L, Chen K, Zhang X, Wei R, Zhang C, Cen B, Xie H, Song P, Liu J, Zheng S, Xu X. Ling S, et al. Among authors: xu l, xu s, xu x. Gut. 2020 Jul;69(7):1322-1334. doi: 10.1136/gutjnl-2019-319616. Epub 2019 Nov 27. Gut. 2020. PMID: 31776228
Hangzhou criteria as downstaging criteria in hepatocellular carcinoma before liver transplantation: A multicenter study from China.
Zhan QF, Ling SB, Deng YN, Shan QN, Ye QW, Xu SJ, Jiang GJ, Lu D, Wei XY, Zhuang L, Zhang W, Shen T, Cen BN, Xie HY, Liu JM, Wu J, Zheng SS, Yang Y, Xu X. Zhan QF, et al. Hepatobiliary Pancreat Dis Int. 2020 Aug;19(4):349-357. doi: 10.1016/j.hbpd.2020.06.011. Epub 2020 Jun 21. Hepatobiliary Pancreat Dis Int. 2020. PMID: 32622826
24,749 results
You have reached the last available page of results. Please see the User Guide for more information.